CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenues:
Revenue, net	$ 7,447	$ 13,122
Costs and expenses:
Cost of revenues	8,610	7,360
Selling, general and administrative expenses	6,717	5,513
Impairment charges	8,373	0
Product development and research expenses	1,800	2,989
Total costs and expenses	25,500	15,862
Operating loss	(18,053)	(2,740)
Other Expense:
Foreign currency exchange loss	(1,597)	(844)
Debt partial extinguishment of 2019 Notes	0	(185)
Interest and other expense, net	(5,876)	(4,947)
Change in the fair value of derivative liabilities	(1,258)	0
Loss before income tax expense	(26,784)	(8,716)
Income tax expense	52	8
Net loss attributable to common shareholders	$ (26,836)	$ (8,724)
Basic and diluted loss per share (in dollars per share)	$ (0.50)	$ (0.16)
Weighted average shares of common stock outstanding:
Basic and diluted shares (in shares)	53,879,333	53,805,983